Literature DB >> 20491577

Effect of extracellular DNA destruction by DNase I on characteristics of forming biofilms.

Victor V Tetz1, George V Tetz.   

Abstract

Biofilm formation plays a crucial role in the development of different infections. This study was designed to examine the effects of extracellular DNA destruction by DNase I on characteristics of forming bacterial biofilms. We have found that extracellular matrix of biofilms formed in the presence of DNase I contains extracellular DNA fragments of about 30 kb. These data support the idea that cell-free DNA is constantly released to the extracellular matrix of bacterial biofilms. Our results indicate that extracellular DNA plays an important role in the properties of forming biofilms. Biofilms formed in the presence of DNase I (5.0 microg/mL) displayed reduced biofilm biomass, total bacterial biomass, decreased viability of bacteria, and decreased tolerance to antibiotics. The fact that destruction of extracellular DNA in forming biofilms by DNase I leads to the formation of an altered microbial community with decreased tolerance to environmental factors suggests the possibility to change the characteristics of forming biofilms by modifying cell-free DNA.

Mesh:

Substances:

Year:  2010        PMID: 20491577     DOI: 10.1089/dna.2009.1011

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  24 in total

1.  Enhancement of photodynamic inactivation of Staphylococcus aureus biofilms by disruptive strategies.

Authors:  Lautaro Gándara; Leandro Mamone; Gabriela Cervini Bohm; Fernanda Buzzola; Adriana Casas
Journal:  Lasers Med Sci       Date:  2017-06-13       Impact factor: 3.161

2.  Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms.

Authors:  Margarida Martins; Mariana Henriques; José L Lopez-Ribot; Rosário Oliveira
Journal:  Mycoses       Date:  2011-06-12       Impact factor: 4.377

3.  Dead or alive: Deoxyribonuclease I sensitive bacteria and implications for the sinus microbiome.

Authors:  Amanda L Willis; Joshua B Calton; Tara F Carr; Alexander G Chiu; Eugene H Chang
Journal:  Am J Rhinol Allergy       Date:  2015-12-28       Impact factor: 2.467

Review 4.  Novel Treatment Strategies for Biofilm-Based Infections.

Authors:  Claudia Vuotto; Gianfranco Donelli
Journal:  Drugs       Date:  2019-10       Impact factor: 9.546

Review 5.  Biologically inspired strategies for combating bacterial biofilms.

Authors:  Meghan S Blackledge; Roberta J Worthington; Christian Melander
Journal:  Curr Opin Pharmacol       Date:  2013-07-18       Impact factor: 5.547

6.  Abundant DNase I-sensitive bacterial DNA in healthy porcine lungs and its implications for the lung microbiome.

Authors:  Alejandro A Pezzulo; Patrick H Kelly; Boulos S Nassar; Cedric J Rutland; Nicholas D Gansemer; Cassie L Dohrn; Andrew J Costello; David A Stoltz; Joseph Zabner
Journal:  Appl Environ Microbiol       Date:  2013-07-19       Impact factor: 4.792

Review 7.  Biofilms in periprosthetic orthopedic infections.

Authors:  Stephen J McConoughey; Rob Howlin; Jeff F Granger; Maurice M Manring; Jason H Calhoun; Mark Shirtliff; Sandeep Kathju; Paul Stoodley
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

8.  Enhanced biofilm formation by Escherichia coli LPS mutants defective in Hep biosynthesis.

Authors:  Ryoma Nakao; Madeleine Ramstedt; Sun Nyunt Wai; Bernt Eric Uhlin
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

9.  Efficacy of a marine bacterial nuclease against biofilm forming microorganisms isolated from chronic rhinosinusitis.

Authors:  Robert C Shields; Norehan Mokhtar; Michael Ford; Michael J Hall; J Grant Burgess; Mohamed Reda ElBadawey; Nicholas S Jakubovics
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

10.  In vitro antimicrobial activity of a novel compound, Mul-1867, against clinically important bacteria.

Authors:  George Tetz; Victor Tetz
Journal:  Antimicrob Resist Infect Control       Date:  2015-11-06       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.